{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:38:59Z","timestamp":1793659139950,"version":"4.5.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41433-021-01470-9","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T16:02:46Z","timestamp":1614960166000},"page":"182-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Real-life patient journey in neovascular age-related macular degeneration: a narrative medicine analysis in the Italian setting"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3132-6233","authenticated-orcid":false,"given":"Edoardo","family":"Midena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Varano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Staurenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Camparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Pece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Battaglia Parodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2726-698X","authenticated-orcid":false,"given":"Maria","family":"Vadal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6920-7021","authenticated-orcid":false,"given":"Simone","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Frizziero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fiorencis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Reale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"1470_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106\u201316.","journal-title":"Lancet Glob Health"},{"key":"1470_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.oret.2017.10.003","volume":"2","author":"GS Ying","year":"2018","unstructured":"Ying GS, Maguire MG, Pan W, Grunwald JE, Daniel E, Jaffe GJ, et al. Baseline predictors for five-year visual acuity outcomes in the comparison of AMD treatment trials. Opthamol Retina. 2018;2:525\u201330.","journal-title":"Opthamol Retina"},{"key":"1470_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/bmb\/ldn012","volume":"85","author":"HL Cook","year":"2008","unstructured":"Cook HL, Patel PJ, Tufail A. Age-related macular degeneration: diagnosis and management. Br Med Bull. 2008;85:127\u201349.","journal-title":"Br Med Bull"},{"key":"1470_CR4","first-page":"S3","volume":"24","author":"CC Wykoff","year":"2018","unstructured":"Wykoff CC, Clark WL, Nielsen JS, Brill JV, Greene LS, Heggen CL. Optimizing anti-VEGF treatment outcomes for patients with neovascular age-related macular degeneration. J Manag Care Spec Pharm. 2018;24:S3\u2013S15.","journal-title":"J Manag Care Spec Pharm"},{"key":"1470_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1749-4486.2011.02320.x","volume":"36","author":"VK Manchaiah","year":"2011","unstructured":"Manchaiah VK, Stephens D, Meredith R. The patient journey of adults with hearing impairment: the patients\u2019 views. Clin Otolaryngol. 2011;36:227\u201334.","journal-title":"Clin Otolaryngol"},{"key":"1470_CR6","first-page":"S14","volume":"188","author":"DI Ben-Tovim","year":"2008","unstructured":"Ben-Tovim DI, Dougherty ML, O\u2019Connell TJ, McGrath KM. Patient journeys: the process of clinical redesign. Med J Aust. 2008;188:S14\u20137.","journal-title":"Med J Aust"},{"key":"1470_CR7","doi-asserted-by":"publisher","first-page":"c4078","DOI":"10.1136\/bmj.c4078","volume":"341","author":"TM Trebble","year":"2010","unstructured":"Trebble TM, Hansi N, Hydes T, Smith MA, Baker M. Process mapping the patient journey: an introduction. BMJ. 2010;341:c4078.","journal-title":"BMJ"},{"key":"1470_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-128","volume":"11","author":"A Sbaraini","year":"2011","unstructured":"Sbaraini A, Carter SM, Evans RW, Blinkhorn A. How to do a grounded theory study: a worked example of a study of dental practices. BMC Med Res Methodol. 2011;11:128.","journal-title":"BMC Med Res Methodol"},{"key":"1470_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3109\/0142159X.2012.704439","volume":"34","author":"CJ Watling","year":"2012","unstructured":"Watling CJ, Lingard L. Grounded theory in medical education research: AMEE Guide No. 70. Med Teach. 2012;34:850\u201361.","journal-title":"Med Teach."},{"key":"1470_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/ACM.0b013e3182446fbb","volume":"87","author":"R Charon","year":"2012","unstructured":"Charon R. At the membranes of care: stories in narrative medicine. Acad Med. 2012;87:342\u20137.","journal-title":"Acad Med"},{"key":"1470_CR11","doi-asserted-by":"crossref","unstructured":"Marini MG. Narrative medicine: bridging the gap between evidence-based care and medical humanities. 1st edn. Switzerland: Springer International Publishing; 2015.","DOI":"10.1007\/978-3-319-22090-1_1"},{"issue":"Suppl 1","key":"1470_CR12","doi-asserted-by":"publisher","first-page":"i10","DOI":"10.1136\/qshc.2005.015859","volume":"15","author":"P Barach","year":"2006","unstructured":"Barach P, Johnson JK. Understanding the complexity of redesigning care around the clinical microsystem. Qual Saf Health Care. 2006;15 Suppl 1:i10\u20136.","journal-title":"Qual Saf Health Care"},{"key":"1470_CR13","unstructured":"Creswell JW. Research design: qualitative, quantitative, and mixed methods approaches. Thousand Oaks: SAGE Publications; 2014."},{"key":"1470_CR14","unstructured":"Corbin J, Strauss A. Basics of qualitative research. Techniques and procedures for developing Grounded Theory. Thousand Oaks: SAGE Publications; 2015."},{"key":"1470_CR15","doi-asserted-by":"publisher","first-page":"126003","DOI":"10.1117\/1.JBO.18.12.126003","volume":"18","author":"E Real","year":"2013","unstructured":"Real E, Eguizabal A, Pont\u00f3n A, D\u00edez MC, Fernando Val-Bernal J, Mayorga M, et al. Optical coherence tomography assessment of vessel wall degradation in thoracic aortic aneurysms. J Biomed Opt. 2013;18:126003.","journal-title":"J Biomed Opt"},{"key":"1470_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/13548506.2014.936886","volume":"20","author":"J Boyle","year":"2015","unstructured":"Boyle J, Vukicevic M, Koklanis K, Itsiopoulos C. Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: a systematic review. Psychol Health Med. 2015;20:296\u2013310.","journal-title":"Psychol Health Med"},{"key":"1470_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ophtha.2008.12.025","volume":"127","author":"PY Chua","year":"2009","unstructured":"Chua PY, Mitrut I, Armbrecht AM, Vani A, Aslam T, Dhillon B. Evaluating patient discomfort, anxiety, and fear before and after ranibizumab intravitreous injection for wet age-related macular degeneration. Arch Ophthalmol. 2009;127:939\u201340.","journal-title":"Arch Ophthalmol"},{"key":"1470_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0264619613490517","volume":"31","author":"AE Burton","year":"2013","unstructured":"Burton AE, Shaw R, Gibson J. Experiences of patients with age-related macular degeneration receiving anti-vascular endothelial growth factor therapy: a qualitative study. Br J Vis Impair. 2013;31:178\u201388.","journal-title":"Br J Vis Impair"},{"key":"1470_CR19","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/eye.2015.167","volume":"29","author":"C McCloud","year":"2015","unstructured":"McCloud C, Lake S. Understanding the patient\u2019s lived experience of neovascular age-related macular degeneration: a qualitative study. Eye. 2015;29:1561\u20139.","journal-title":"Eye"},{"key":"1470_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/OPTH.S92616","volume":"10","author":"M Varano","year":"2016","unstructured":"Varano M, Eter N, Winyard S, Wittrup-Jensen KU, Navarro R, Heraghty J. The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey. Clin Ophthalmol. 2016;10:257\u201367.","journal-title":"Clin Ophthalmol"},{"key":"1470_CR21","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00417-016-3384-0","volume":"254","author":"H Senra","year":"2016","unstructured":"Senra H, Ali Z, Balaskas K, Aslam T. Psychological impact of anti-VEGF treatments for wet macular degeneration\u2014a review. Graefes Arch Clin Exp Ophthalmol. 2016;254:1873\u201380.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1470_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-14-78","volume":"14","author":"SR Dawson","year":"2014","unstructured":"Dawson SR, Mallen CD, Gouldstone MB, Yarham R, Mansell G. The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data. BMC Ophthalmol. 2014;14:78.","journal-title":"BMC Ophthalmol"},{"key":"1470_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fnagi.2013.00056","volume":"5","author":"R Eramudugolla","year":"2013","unstructured":"Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults. Front Aging Neurosci 2013;5:56.","journal-title":"Front Aging Neurosci"},{"key":"1470_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/IAE.0b013e3181eac724","volume":"31","author":"GR Blaha","year":"2011","unstructured":"Blaha GR, Tilton EP, Barouch FC, Marx JL. Randomized trial of anesthetic methods for intravitreal injections. Retina. 2011;31:535\u20139.","journal-title":"Retina"},{"key":"1470_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11136-008-9327-4","volume":"17","author":"RP Finger","year":"2008","unstructured":"Finger RP, Fleckenstein M, Holz FG, Scholl HP. Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools. Qual Life Res. 2008;17:559\u201374.","journal-title":"Qual Life Res"},{"key":"1470_CR26","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.ophtha.2014.05.002","volume":"121","author":"BW Rovner","year":"2014","unstructured":"Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Ho AC, et al. Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2014;121:2204\u201311.","journal-title":"Ophthalmology"},{"key":"1470_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41433-019-0445-8","volume":"34","author":"DJ Taylor","year":"2020","unstructured":"Taylor DJ, Jones L, Binns AM, Crabb DP. \u2018You\u2019ve got dry macular degeneration, end of story\u2019: a qualitative study into the experience of living with non-neovascular age-related macular degeneration [published correction appears in Eye (Lond). 2019 Sep 5]. Eye. 2020;34:461\u201373.","journal-title":"Eye."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01470-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01470-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01470-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T13:21:58Z","timestamp":1697980918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01470-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01470-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"7 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MBP has participated in advisory boards of Novartis and Bayer; EM, MVarano, EP, GS, MC, AP, MVadal\u00e0, SD, LF, AF, MGM and LR declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was submitted for approval to the Ethics Committee before beginning the collection of narratives. Before enrolment, all participants signed an informed consent, as foreseen by the Italian Law on <i>Privacy and safeguard of sensitive data<\/i>, with particular regard to: the aims of the project; the handling of personal data and of any reference to people, places, and treatments; the possibility to withdraw from the study at any time; the confidentiality in reporting the results. The entire study was performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}